191 related articles for article (PubMed ID: 30928532)
1. Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.
Romano ME; Braun-Courville DK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):409-414. PubMed ID: 30928532
[TBL] [Abstract][Full Text] [Related]
2. Weight change at 12 months in users of three progestin-only contraceptive methods.
Vickery Z; Madden T; Zhao Q; Secura GM; Allsworth JE; Peipert JF
Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
[TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
Bahamondes L; Brache V; Ali M; Habib N;
Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
[TBL] [Abstract][Full Text] [Related]
4. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
Deokar AM; Jackson W; Omar HA
Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
6. Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome.
Buyers E; Sass AE; Severn CD; Pyle L; Cree-Green M
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):33-39. PubMed ID: 32919086
[TBL] [Abstract][Full Text] [Related]
7. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.
Berlan E; Mizraji K; Bonny AE
Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183
[TBL] [Abstract][Full Text] [Related]
8. Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant.
Modesto W; Dal Ava N; Monteiro I; Bahamondes L
Arch Gynecol Obstet; 2015 Dec; 292(6):1387-91. PubMed ID: 26088190
[TBL] [Abstract][Full Text] [Related]
9. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
[TBL] [Abstract][Full Text] [Related]
10. Postpartum weight loss in overweight and obese women using the etonogestrel subdermal implant: a pilot study.
Griffin L; Hammond C; Liu D; Rademaker AW; Kiley J
Contraception; 2017 Jun; 95(6):564-570. PubMed ID: 28238839
[TBL] [Abstract][Full Text] [Related]
11. Does Obesity Influence Body Mass Index Changes in Nulliparous Adolescent Users of Long-Acting Reversible Contraceptives?
Scott N; Silver EJ; Dodson NA; Coupey SM
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):815-820. PubMed ID: 34389461
[TBL] [Abstract][Full Text] [Related]
12. Association of Etonogestrel-Releasing Contraceptive Implant with Reduced Weight Gain in an Exclusively Breastfed Infant: Report and Literature Review.
Stuebe AM; Bryant AG; Lewis R; Muddana A
Breastfeed Med; 2016 May; 11(4):203-6. PubMed ID: 27032034
[TBL] [Abstract][Full Text] [Related]
13. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
14. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
[TBL] [Abstract][Full Text] [Related]
15. An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users.
Lazorwitz A; Dindinger E; Harrison M; Aquilante CL; Sheeder J; Teal S
Contraception; 2020 Sep; 102(3):180-185. PubMed ID: 32407811
[TBL] [Abstract][Full Text] [Related]
16. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol.
Barbieri MM; Juliato CRT; Bahamondes L; Surita FG
Reprod Health; 2020 Jun; 17(1):100. PubMed ID: 32576199
[TBL] [Abstract][Full Text] [Related]
17. Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period.
Villas-Boas J; Vilodre LC; Malerba H; Pontremoli Salcedo M; Foresti Jiménez M; El Beitune P
Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():51-4. PubMed ID: 27164485
[TBL] [Abstract][Full Text] [Related]
18. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
Wilson S; Tennant C; Sammel MD; Schreiber C
Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
[TBL] [Abstract][Full Text] [Related]
19. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
Lew J; Sheeder J; Lazorwitz A
Contraception; 2021 Nov; 104(5):556-560. PubMed ID: 34147509
[TBL] [Abstract][Full Text] [Related]
20. Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year.
Morrell KM; Cremers S; Westhoff CL; Davis AR
Contraception; 2016 Mar; 93(3):263-5. PubMed ID: 26577754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
